They’re developing, licensing and producing marketable products.
Heaps of other companies are queuing up to stuff cash and shares
into Mithra’s pockets and cutting deals left right and centre in order
to get a piece of the action. It would be little surprise that their share
price is tracking higher Pat. Mithra is the company sitting on a potential
price explosive gold mine not Mayne IMO. Mayne was in trouble after the
Teva debacle and sees Mithra as its lifeline but Mithra isn’t giving away
its product for chicken feed and nor should it to bail SR out for poor decisions
previously made. Mithra will have almost 10% of Mayne by time E4 hits
the market, then there’s their pre/peri/post menopausal products yet to be
acquired by Mayne.....Wonder how much of Mayne Mithra will own in a few
years time in order to access these additional products .........Again if this
is such a brilliant deal for MYX then why is the market pricing Mayne where
it was 10 years ago? The market is quite capable of doing its number crunching
on E4 and Myring and this is the result.
Mayne is attempting to make up for previous share dilution and shrinking profits and
labels earnings as “volatile.”
SR is very careful with his historical language choice. If you change
volatile to shrinking or dwindling profits it sounds far less palatable so he dresses
up the language to make it sound better and then blames external forces and the market in
general. SR is very politician like. Very little blame acknowledged/accepted but
if E4 becomes lucrative then he’ll become a self proclaimed genius like Trump.
Let him tell that to those who bought in on the CR in 2016!!!!!
So for those who bought in at $2 in order to double your money you need this company
to go up in value 10 X today’s price which will have the co valued at about circa $7 billion.
And for those who bought in 4 years ago at the CR price you’ll need it to go up 5X in value
just to get your initial “investment” back! No wonder the market sits back with skepticism yet
again with SR at the helm and the continual information void.
Myx’s earnings over the last 10 years are not volatile they are just plain poor as reflected in
the share price And who has been CEO for that period of time?
Oh give the guy another chance....Reality is retails have no say anyway. This is why Myx becomes
a traders paradise IMO. Everyone wants to believe the sales pitch dream but many others are stuck
in the doubled down reality nightmare of Myx. In too deep to sell out or trade out. Luckily that’s not me.
- Forums
- ASX - By Stock
- Is MYX a bargain
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

They’re developing, licensing and producing marketable...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
2 | 3150 | 5.040 |
1 | 600 | 5.030 |
3 | 3000 | 5.000 |
1 | 10000 | 4.980 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.180 | 2396 | 2 |
5.190 | 5000 | 1 |
5.200 | 157 | 1 |
5.210 | 5000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online